Day: October 9, 2023

Investors Include Well Known Uranium and Critical Resource Investor Tees River, through its Tees River Critical Resources Fund and Members of the Board WASHINGTON, Oct. 09, 2023 (GLOBE NEWSWIRE) — ASP Isotopes Inc. (NASDAQ:ASPI) (“ASPI”, the “Company”, “us”, “we” or “our”), an advanced materials company dedicated to the development of technology and processes designed to produce isotopes for use in multiple industries, today announced that it has entered into a definitive securities purchase agreement with certain institutional and other accredited investors, under which the Company agreed to issue an aggregate of approximately 9 million shares of its common stock at a purchase price of $0.9105 per share in a private placement transaction. The oversubscribed private placement...

Webcast at 4:15pm ET/1:15pm PT on Wednesday, Oct. 25SAN DIEGO, Oct. 09, 2023 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced it will host a virtual R&D event for the investment community on rosnilimab, a PD-1 agonist antibody, at 4:15pm ET/1:15pm PT on Wednesday, Oct. 25. Independent medical experts and members of Anaptys senior management will discuss:PD-1 biology and rosnilimab’s mechanism of action Rheumatoid arthritis: Unmet need, market opportunity and Phase 2 development plan which initiated in August Second indication (to be unveiled during this webcast): Unmet need, market opportunity and Phase 2 development plan which will initiate in Q4 2023The approximately 90-minute event will be followed...

The comprehensive range of innovative solutions provides remote and autonomous platforms a technological edge in a wide range of law enforcement, homeland security and defense applications Rehovot, Israel, Oct. 09, 2023 (GLOBE NEWSWIRE) — Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech” or the “Company”), a B2B provider of AI accelerated video solutions for edge platforms, today announced its participation in the upcoming Milipol Paris 2023 (November 14-17,2023) at the Paris Norde Villepinte exhibition (“Milipol Paris 2023”). The Company will showcase its high-performance intelligence gathering solutions for remote and autonomous platforms – powered by artifical intelligence (“AI”) at booth 014, Hall 4E. During Milipol Paris, the Company will demonstrate the capabilities of its innovative Jupiter family, including the recently...

MALMÖ, Sweden, Oct. 09, 2023 (GLOBE NEWSWIRE) — Oatly Group AB (Nasdaq: OTLY), the world’s original and largest oat drink company, will report financial results for the third quarter ended September 30, 2023, on Thursday, November 9, 2023, before the U.S. market opens. Oatly will host a conference call and webcast at 8:30 a.m. ET on the same day to discuss the results. The conference call and simultaneous live webcast can be accessed on Oatly’s Investors website at https://investors.oatly.com under “Events.” The webcast will be archived for 30 days. About Oatly We are the world’s original and largest oat drink company. For over 25 years, we have exclusively focused on developing expertise around oats: a global power crop with inherent properties suited for sustainability and human health. Our commitment to oats has resulted in...

– Early assessment of increased glycosylated ⍺DG levels at 3 months predicted subsequent ambulatory improvements at 9 months, supporting the use of glycosylated ⍺DG levels as a potential surrogate endpoint in LGDM2I/R9 – Long-term data from the ongoing Phase 2 study of BBP-418 in patients with LGMD2I/R9 at Month 21 demonstrate a well-tolerated safety profile, and stabilization in 10 meter walk test (10MWT), 100-m timed test (100mTT), and the North Star Assessment (NSAD) scores – A sustained decrease of ≥80% in creatine kinase (CK), a marker of muscle breakdown, was observed with BBP-418 treatment at 21 months – The Phase 3 study continues to enroll in the U.S. and BridgeBio believes there is potential to pursue Accelerated Approval for BBP-418 based on recent interactions with the U.S. Food and Drug Administration...

ResGreen’s BotWay SoftwareResGreen’s BotWay software integrates easily with Intellistore’s ASRS, as well as vehicles and equipment from other suppliers.SHELBY TOWNSHIP, Mich., Oct. 09, 2023 (GLOBE NEWSWIRE) — ResGreen Group International, Inc. (RGGI) (OTC PINK: RGGI), a next-gen mobile robot and software solutions company, announced today a strategic partnership with Intellistore USA, a smart intralogistics solutions provider, to increase sales by offering complete automation solutions to customers. Intellistore provides high-tech Automated Storage and Retrieval Systems (ASRS) that can be easily integrated with ResGreen’s BotWay software, Automatic Guided Vehicles (AGVs) and Autonomous Mobile Robots (AMRs). As a distributor, Intellistore will sell, integrate and install ResGreen’s products to customers throughout...

Topline data results from the STRIDE study are expected in December 2023 IRVINE, Calif., Oct. 09, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical-stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, announced last patient last visit (LPLV) in the pivotal STRIDE study of mavodelpar in PMM. Topline data results from the STRIDE study are expected in December 2023. “This marks a major milestone for mavodelpar and the company. This achievement reached in the STRIDE program underscores the significant progress toward our corporate mission to bring therapies to patients with rare genetic mitochondrial diseases. We anticipate sharing topline results from the STRIDE clinical trial in December 2023,” said Gregory J....

Please find enclosed the presentation in relation to Frontline plc´s investor call to be held on the webcast / conference call October 9, 2023 at 15:00 CET. This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.AttachmentInvestor Presentation – October 9 2023